0000000000248780

AUTHOR

André F. Carvalho

showing 43 related works from this author

Pain and severe sleep disturbance in the general population: Primary data and meta-analysis from 240,820 people across 45 low- and middle-income coun…

2018

Objective:\ud Pain and sleep disturbances are widespread, and are an important cause of a reduced quality of life. Despite this, there is a paucity of multinational population data assessing the association between pain and sleep problems, particularly among low- and middle-income countries (LMICs). Therefore, we investigated the relationship between pain and severe sleep disturbance across 45 LMICs.\ud \ud Method: \ud Community-based data on 240,820 people recruited via the World Health Survey were analyzed. Multivariable logistic regression analyses adjusted for multiple confounders were performed to quantify the association between pain and severe sleep problems in the last 30 days. A me…

AdultMaleSleep Wake Disordersmedicine.medical_specialtySleep Pain Sleep disturbance Psychiatry Low- and middle-income countries*Low- and middle-income countriesPopulationSleep disturbancePainSleep Wake DisordersComorbidityAnxietyGlobal Health03 medical and health sciences*Sleep0302 clinical medicine*PainmedicineInsomniaHumans030212 general & internal medicineeducationDeveloping CountriesDepression (differential diagnoses)Psychiatryeducation.field_of_studySleep disorderLow- and middle-income countriesbusiness.industryDepressionLow- and middle-income countries; Pain; Psychiatry; Sleep; Sleep disturbance; Psychiatry and Mental HealthOdds ratio*Sleep disturbanceMiddle Agedmedicine.diseaseComorbidityHealth SurveysPsychiatry and Mental healthRC0321Physical therapyAnxiety*PsychiatryFemalemedicine.symptomSleepbusiness030217 neurology & neurosurgeryStress PsychologicalGeneral hospital psychiatry
researchProduct

Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analys…

2017

People with severe mental illness (SMI) – schizophrenia, bipolar disorder and major depressive disorder – appear at risk for cardiovascular disease (CVD), but a comprehensive meta-analysis is lacking. We conducted a large-scale meta-analysis assessing the prevalence and incidence of CVD; coronary heart disease; stroke, transient ischemic attack or cerebrovascular disease; congestive heart failure; peripheral vascular disease; and CVD-related death in SMI patients (N=3,211,768) versus controls (N=113,383,368) (92 studies). The pooled CVD prevalence in SMI patients (mean age 50 years) was 9.9% (95% CI: 7.4-13.3). Adjusting for a median of seven confounders, patients had significantly higher o…

medicine.medical_specialtyCardiovascular disease; bipolar disorder; cerebrovascular disease; congestive heart failure; coronary heart disease; major depression; premature mortality; schizophrenia; severe mental illness03 medical and health sciences0302 clinical medicinesevere mental illnessMedicineCardiovascular disease severe mental illness schizophrenia bipolar disorder major depression coronary heart disease cerebrovascular disease congestive heart failure premature mortalitycoronary heart diseasePsychiatrybipolar disorderFramingham Risk Scorebusiness.industryVascular diseaseIncidence (epidemiology)Hazard ratioCorrectionOdds ratiomedicine.diseaseCardiovascular disease030227 psychiatrycerebrovascular diseaseschizophreniaPsychiatry and Mental healthcongestive heart failurepremature mortalityHeart failureMajor depressive disorderPshychiatric Mental Healthbusinessmajor depressionBody mass index030217 neurology & neurosurgery
researchProduct

The relationship between genetic risk variants with brain structure and function in bipolar disorder: A systematic review of genetic-neuroimaging stu…

2017

Genetic-neuroimaging paradigms could provide insights regarding the pathophysiology of bipolar disorder (BD). Nevertheless, findings have been inconsistent across studies. A systematic review of gene-imaging studies involving individuals with BD was conducted across electronic major databases from inception until January 9th, 2017. Forty-four studies met eligibility criteria (N = 2122 BD participants). Twenty-six gene variants were investigated across candidate gene studies and 4 studies used a genome-wide association approach. Replicated evidence (i.e. in >2 studies) suggests that individuals with BD carrying the BDNF Val66Met risk allele could have reduced hippocampal volumes compared …

Transtorno BipolarCandidate genediffusion tensor imagingvoxel based morphometryBipolar disorderBipolar disorder Genetic polymorphisms Neuroimaging Magnetic resonance imaging Functional MRI Diffusion tensor imagingvoxel based morphometryCognitive NeuroscienceBrain Structure and FunctionGenome-wide association studyNeuroimagingComputational biologyGenetic polymorphismsFaculty of Social Sciences03 medical and health sciencesDISC1Behavioral Neuroscience0302 clinical medicineMagnetic resonance imagingNeuroimaginggenetic polymorphisms/dk/atira/pure/core/keywords/FacultyOfSocialSciencesImatges per ressonància magnèticamedicineHumansManic-depressive illnessANK3Bipolar disorderCervellNeuroimagemDiffusion tensor imagingvoxel based morphometryFunctional MRIGenetic polymorphismneuroimagingTrastorn bipolarbiologyBipolar disorder; Diffusion tensor imagingvoxel based morphometry; Functional MRI; Genetic polymorphisms; Magnetic resonance imaging; Neuroimaging; Neuropsychology and Physiological Psychology; Cognitive Neuroscience; Behavioral NeuroscienceReproducibility of ResultsBrainmedicine.disease030227 psychiatryNeuropsychology and Physiological Psychology5-HTTLPRbiology.proteinfunctional MRIImagem por Ressonância MagnéticaPsychologyNeuroscience030217 neurology & neurosurgeryHumanGenome-Wide Association Study
researchProduct

Multimorbidity and perceived stress: a population-based cross-sectional study among older adults across six low- and middle-income countries

2018

BACKGROUND:\ud Stress in chronic conditions or multimorbidity (≥2 chronic conditions) has been reported to affect clinical outcomes but there are no studies on the association between stress and chronic conditions/multimorbidity among older adults in low- and middle-income countries (LMICs). Thus, we investigated this association among adults aged ≥50 years across six LMICs.\ud \ud METHODS:\ud A cross-sectional analysis using data from the World Health Organization's Study on Global Ageing and Adult Health (China, Ghana, India, Mexico, Russia, South Africa) was conducted. A perceived stress score [range 0 (lowest stress) -100 (highest stress)] was computed based on two questions from the Pe…

GerontologyMaleCross-sectional studyPsychological interventionPerceived Stress ScaleGlobal HealthGhanaRussiachronic diseasesSouth Africastress0302 clinical medicineStress (linguistics)Prevalence030212 general & internal medicinelow- and middle-income countriesStrokeDepression (differential diagnoses)older adultsAged 80 and overPsychiatryLow- and middle-income countriesDepressionObstetrics and GynecologyMiddle AgedpsychiatryOlder adultschronic diseases; low- and middle-income countries; multimorbidity; older adults; psychiatry; stressFemaleChinamultimorbidityBFIndiaAffect (psychology)StressGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciencesmedicineHumansBackground StreDeveloping CountriesMexicoPovertyAgedbusiness.industryMultimorbiditymedicine.diseaseCross-Sectional StudiesAgeingChronic diseasesChronic DiseasePerceptionbusiness030217 neurology & neurosurgeryStress PsychologicalDemography
researchProduct

Prevalence and correlates of major depressive disorder, bipolar disorder and schizophrenia among nursing home residents without dementia: Systematic …

2020

BackgroundThe elderly population and numbers of nursing homes residents are growing at a rapid pace globally. Uncertainty exists regarding the actual rates of major depressive disorder (MDD), bipolar disorder and schizophrenia as previous evidence documenting high rates relies on suboptimal methodology.AimsTo carry out a systematic review and meta-analysis on the prevalence and correlates of MDD, bipolar disorder and schizophrenia spectrum disorder among nursing homes residents without dementia.MethodMajor electronic databases were systematically searched from 1980 to July 2017 for original studies reporting on the prevalence and correlates of MDD among nursing homes residents without demen…

medicine.medical_specialtyBipolar Disorderdepressive disorder (MDD)PopulationreviewPrevalenceMajor depressive disordernursing homesbehavioral disciplines and activitiesmeta-analysi03 medical and health sciences0302 clinical medicinemental disordersPrevalencemedicineHumansDementiaBipolar disorderPsychiatryeducationAgedDepressive Disorder Majoreducation.field_of_study030214 geriatricsbusiness.industryPublication biasmedicine.diseaseNursing Homes030227 psychiatrymeta-analysisnursing homePsychiatry and Mental healthSchizophreniaMeta-analysisSchizophrenialong-term careMajor depressive disorderDementiabusiness
researchProduct

Prevalence and Psychosocial Correlates of Mental Health Outcomes Among Chinese College Students During the Coronavirus Disease (COVID-19) Pandemic.

2020

Objectives: To investigate the prevalence and risk factors for poor mental health of Chinese university students during the Corona Virus Disease 2019 (COVID-19) pandemic. Method: Chinese nation-wide on-line cross-sectional survey on university students, collected between February 12th and 17th, 2020. Primary outcome was prevalence of clinically-relevant posttraumatic stress disorder symptoms. Secondary outcomes on poor mental health included prevalence of clinically-relevant anxiety and depressive symptoms, while posttraumatic growth was considered as indicator of effective coping reaction. Results: Of 2,500 invited Chinese university students, 2,038 completed the survey. Prevalence of clin…

Coping (psychology)lcsh:RC435-571Psychological interventionposttraumaticDisease03 medical and health sciences0302 clinical medicinelcsh:PsychiatryMedicineuniversity studentsSocial isolationOriginal ResearchPsychiatrybusiness.industryPosttraumatic growthpandemicCOVID-19anxietyMental health030227 psychiatryPsychiatry and Mental healthCOVID-19 pandemic posttraumatic anxiety depression university studentsdepressionAnxietymedicine.symptombusinessPsychosocial030217 neurology & neurosurgeryClinical psychologyFrontiers in Psychiatry
researchProduct

Aspirin and incident depressive symptoms: A longitudinal cohort study over 8 years

2017

Objective: Aspirin exhibits anti-atherosclerotic and anti-inflammatory properties—two potential risk factors for depression. The relationship between aspirin use and depression, however, remains unclear. We investigated whether the aspirin use is associated with a decreased incidence of depressive symptoms in a large North American cohort. Methods: Data from the Osteoarthritis Initiative dataset, a multicenter, longitudinal study on community-dwelling adults was analyzed. Aspirin use was defined through self-report in the past 30 days and confirmed by a trained interviewer. Incident depressive symptoms were defined as a score of ≥16 in the 20-item Center for Epidemiologic Studies-Depression…

Malemedicine.medical_specialtyLongitudinal studyEpidemiologyAspirin; Cohort; Depression; Epidemiology; Psychiatry; Survey; Geriatrics and Gerontology; Psychiatry and Mental Healthaspirin cohort depression epidemiology psychiatry surveyArticle03 medical and health sciences0302 clinical medicine*aspirinFibrinolytic AgentsInternal medicineMedicineHumansLongitudinal Studies*epidemiologySurveyAgedProportional Hazards Models*surveyPsychiatryAspirinDepressive Disorder*cohortAspirinbusiness.industryProportional hazards modelDepressionIncidence (epidemiology)IncidenceHazard ratioAnti-Inflammatory Agents Non-SteroidalCohortMiddle Aged030227 psychiatryPsychiatry and Mental Health*psychiatryCohortPropensity score matchingPhysical therapyRegression AnalysisFemaleGeriatrics and Gerontologybusiness*depression030217 neurology & neurosurgeryFibrinolytic agentmedicine.drug
researchProduct

Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta…

2017

Mounting evidence suggests that aberrations in immune-inflammatory pathways contribute to the pathophysiology of major depressive disorder (MDD), and individuals with MDD may have elevated levels of predominantly pro-inflammatory cytokines and C-reactive protein. In addition, previous meta-analyses suggest that antidepressant drug treatment may decrease peripheral levels of interleukin-1 beta (IL-1β) and IL-6. Recently, several new studies examining the effect of antidepressants on these cytokines have been published, and so we performed an updated meta-analysis of studies that measured peripheral levels of cytokines and chemokines during antidepressant treatment in patients with MDD. The P…

epressionChemokinemedicine.drug_classmedicine.medical_treatmentNeuroscience (miscellaneous)InflammationAntidepressantPharmacology03 medical and health sciencesCellular and Molecular Neuroscience0302 clinical medicinemedicineHumansMeta-analysiCytokineInflammationDepressive Disorder MajorbiologyDepressionbusiness.industrymedicine.diseaseReceptor antagonistAntidepressive Agents030227 psychiatryMeta-analysisCytokineTreatment OutcomeAntidepressant; Chemokines; Cytokines; Depression; Inflammation; Meta-analysis; Cellular and Molecular NeuroscienceNeurologyChemokineMeta-analysisbiology.proteinCytokinesMajor depressive disorderAntidepressantTumor necrosis factor alphamedicine.symptomChemokinesbusiness030217 neurology & neurosurgeryMolecular neurobiology
researchProduct

Efficacy, safety and tolerability of aripiprazole in bipolar disorder: An updated systematic review and meta-analysis of randomized controlled trials

2017

Numerous studies have investigated aripiprazole as a treatment for bipolar disorder (BD). therefore we conducted this comprehensive meta-analysis to investigate the efficacy and safety profile of aripiprazole in treating BD. Two authors conducted systematic searches of PubMed and ScienceDirect from inception until May 14th, 2017. Randomized controlled trials (RCTs) of people with BD who received aripiprazole were included. A total of 20 RCTs met the eligibility criteria, including two which investigated the efficacy of aripiprazole versus haloperidol (aripiprazole = 340; haloperidol = 337), three which compared aripiprazole versus lithium (aripiprazole = 208; lithium = 212), and 15 with mul…

Transtorno Bipolarmedicine.medical_specialtyEfficacyBipolar disorderAripiprazolePlacebolaw.invention03 medical and health sciences0302 clinical medicineMaintenance therapyRandomized controlled trialAripiprazole; Bipolar disorder; Efficacy; Meta-analysis; Tolerability; Pharmacology; Biological PsychiatrylawInternal medicinemedicineHaloperidolHumansMeta-analysiBipolar disorderPsychiatryBiological PsychiatryRandomized Controlled Trials as TopicAripiprazole Bipolar disorder Efficacy Tolerability Meta-analysisPharmacologymedicine.diseaseTolerability030227 psychiatryMeta-analysisAripiprazolTolerabilityMeta-analysisAripiprazolePsychology030217 neurology & neurosurgeryAntipsychotic Agentsmedicine.drug
researchProduct

Relationship between sedentary behavior and depression: a mediation analysis of influential factors across the lifespan among 42,469 people in low- a…

2018

Abstract Background Sedentary behavior (SB) is associated with diabetes, cardiovascular disease and low mood. There is a paucity of multi-national research investigating SB and depression, particularly among low- and middle-income countries. This study investigated the association between SB and depression, and factors which influence this. Methods Cross-sectional data were analyzed from the World Health Organization's Study on Global Ageing and Adult Health. Depression was based on the Composite International Diagnostic Interview. The association between depression and SB (self-report) was estimated by multivariable linear and logistic regression analyses. Mediation analysis was used to id…

AdultMaleCross-sectional study*Low- and middle-income countriesExercício*SittingLogistic regressionBody Mass IndexYoung Adult03 medical and health sciences0302 clinical medicine*Sedentary behaviorPrevalencemedicineHumans030212 general & internal medicineYoung adultDeveloping CountriesExerciseDepression (differential diagnoses)AgedSedentary lifestyleDepressive DisorderLow- and middle-income countriesDepressionPhysical activitybusiness.industryMiddle Aged*DepressionSedentary behaviorPsychiatry and Mental healthClinical Psychology*Physical activityCross-Sectional StudiesLogistic ModelsMoodAnxietySedentary behavior Sitting Physical activity Depression Low- and middle-income countriesFemaleDepressãoSedentary Behaviormedicine.symptombusinessDepression; Low- and middle-income countries; Physical activity; Sedentary behavior; Sitting; Clinical Psychology; Psychiatry and Mental HealthBody mass indexSitting030217 neurology & neurosurgeryDemography
researchProduct

Lifetime self-reported arthritis is associated with elevated levels of mental health burden: A multi-national cross sectional study across 46 low- an…

2017

Population-based studies investigating the relationship of arthritis with mental health outcomes are lacking, particularly among low- and middle-income countries (LMICs). We investigated the relationship between arthritis and mental health (depression spectrum, psychosis spectrum, anxiety, sleep disturbances and stress) across community-dwelling adults aged ≥18 years across 46 countries from the World Health Survey. Symptoms of psychosis and depression were established using questions from the Mental Health Composite International Diagnostic Interview. Severity of anxiety, sleep problems, and stress sensitivity over the preceding 30 days were self-reported. Self-report lifetime history of a…

MaleCross-sectional studyPsychological interventionArthritisComorbidityGlobal Health0302 clinical medicineQUALITY-OF-LIFEOdds RatioPrevalencePublic Health Surveillance030212 general & internal medicineGENERAL-POPULATIONINFECTED PATIENTSeducation.field_of_studyMultidisciplinaryQRMiddle Aged3. Good healthMental HealthDEPRESSIVE SYMPTOMSIncomeMedicineAnxietyFemalemedicine.symptomAdultmedicine.medical_specialtySciencePopulationArticleYoung Adult03 medical and health sciencesmedicineHumansPsychiatryeducationDeveloping CountriesSLEEP PROBLEMSbusiness.industryArthritisOdds ratioGLOBAL BURDENSTRESS SENSITIVITYmedicine.diseaseComorbidityMental healthPSYCHOTIC EXPERIENCESRHEUMATOID-ARTHRITISCross-Sectional StudiesPHYSICAL-ACTIVITYSocial ClassSelf Reportbusiness030217 neurology & neurosurgeryScientific Reports
researchProduct

Chronic skin disease and levels of physical activity in 17 777 Spanish adults: a cross-sectional study

2021

Background: To date there is limited literature on the prevalence of chronic skin conditions and its association with levels of physical activity (PA) in Spain. Aim: To determine the prevalence of chronic skin disease and to compare levels of PA between people with and without chronic skin disease in a large representative sample of Spanish adults aged 15–69 years. Methods: Data from the Spanish National Health Survey 2017 were analysed. Chronic skin disease was assessed using a yes/no question. PA was measured using the short form of the International Physical Activity Questionnaire. Total PA metabolic equivalent of task min/week were calculated, and PA was included in the analyses as a co…

AdultMalemedicine.medical_specialtyAdolescentCross-sectional study[SDV]Life Sciences [q-bio]Physical activityDermatologyNegative associationSkin DiseasesMetabolic equivalentYoung Adult030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineInternal medicinePrevalencemedicineHumansChronic skin diseaseSex DistributionExerciseAgedNational healthbusiness.industryConfoundingOdds ratioMiddle AgedCross-Sectional StudiesChronic skin diseaseSpain030220 oncology & carcinogenesisChronic DiseaseFemalebusiness
researchProduct

Systematic review and meta-analysis of the efficacy and safety of minocycline in schizophrenia

2017

ObjectiveOur aim was to perform an updated systematic review and meta-analysis on the efficacy and safety of adjunctive minocycline as a treatment of schizophrenia.MethodsWe conducted a PubMed/Scopus database search from inception to 3 February 2016 for randomized, placebo-controlled trials (RCTs), open non-randomized studies, and case reports/series evaluating minocycline in patients with schizophrenia. Random-effects meta-analysis of positive, negative, depressive, and cognitive symptom rating scales, discontinuation and adverse effects rates calculating standardized mean difference (SMD), and risk ratios±95% confidence intervals (CI95%) were calculated.ResultsSix RCTs were eligible (mino…

safetymedicine.medical_specialtyefficacyMinocyclinePlacebometa-analysi03 medical and health sciences0302 clinical medicinesystematic reviewInternal medicineefficacy; meta-analysis; Minocycline; safety; schizophrenia; systematic review; Neurology (clinical); Psychiatry and Mental HealthMedicineHumansRandomized Controlled Trials as TopicPositive and Negative Syndrome Scalebusiness.industryMinocycline schizophrenia efficacy safety meta-analysis systematic reviewConfidence interval030227 psychiatryDiscontinuationAnti-Bacterial Agentsmeta-analysisschizophreniaTolerabilityStrictly standardized mean differencePsychiatry and Mental HealthMeta-analysisAdjunctive treatmentNeurology (clinical)business030217 neurology & neurosurgeryAntipsychotic Agents
researchProduct

Mitochondrial genetic haplogroups and depressive symptoms: A large study among people in North America.

2017

Background:\ud A possible relationship between mitochondrial haplogroups and psychiatric diseases (e.g. schizophrenia and bipolar disorder) has been postulated, but data regarding depression is still limited. We investigated whether any mitochondrial haplogroup carried a significant higher risk of depressive symptoms in a large prospective cohort of North American people included in the Osteoarthritis Initiative.\ud \ud Methods:\ud Cross sectional data was derived from the Osteoarthritis Initiative. The haplogroup was assigned through a combination of sequencing and PCR-RFLP techniques. All the mitochondrial haplogroups were named following this nomenclature: H, U, K, J, T, V, SuperHV, I, W…

0301 basic medicineMalemitochondrial haplogroupsCross-sectional studyHaplogroup H*Osteoarthritis initiativePopulation*Mitochondrial haplogroupsDNA MitochondrialHaplogroupArticleWhite People03 medical and health sciences0302 clinical medicineMedicineHumansGenetic Predisposition to DiseaseBipolar disorderProspective Studieseducationeducation.field_of_studybusiness.industryDepressionHaplotypeOsteoarthritis initiativeMiddle Agedmedicine.disease*Depressionhumanities3. Good healthDepression; Mitochondrial haplogroups; Osteoarthritis initiative; Clinical Psychology; Psychiatry and Mental HealthClinical PsychologyMitochondrial haplogroups Depression Osteoarthritis initiative030104 developmental biologyMoodCross-Sectional StudiesHaplotypesPsychiatry and Mental HealthNorth AmericadepressionMitochondrial haplogroupsFemalebusinessosteoarthritis initiative030217 neurology & neurosurgeryHuman mitochondrial DNA haplogroupDemographyClinical psychology
researchProduct

Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review

2017

Marco Solmi,1,2 Andrea Murru,3 Isabella Pacchiarotti,3 Juan Undurraga,4,5 Nicola Veronese,2,6 Michele Fornaro,7,8 Brendon Stubbs,2,9–11 Francesco Monaco,2 Eduard Vieta,3 Mary V Seeman,12 Christoph U Correll,13,14 André F Carvalho2,15 1Neuroscience Department, University of Padua, 2Institute for Clinical Research and Education in Medicine, Padua, Italy; 3Bipolar Disorders Unit, Institute of Neuroscience, Hospital Clínic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain; 4Department of Psychiatry, Faculty of Medicine, Clínica Alemana Universidad del Desarrollo, 5Early Intervention Program, J. Horwitz Psychiatric Institute, Santiago, Chile; 6Na…

Olanzapinesafetymedicine.medical_specialtyside effectToxicology and Pharmaceutics (all)ReviewRM1-950psychosi03 medical and health sciencesIloperidonechemistry.chemical_compound0302 clinical medicineSertindoleJournal ArticlemedicineAsenapinePharmacology (medical)psychosisGeneral Pharmacology Toxicology and PharmaceuticstolerabilityPsychiatryLurasidoneBrexpiprazolePharmacologyChemical Health and Safetybusiness.industryMedicine (all)Transtornos PsicóticosGeneral Medicinepsychiatry3. Good health030227 psychiatryantipsychotics side effects tolerability safety psychosis psychiatryantipsychoticantipsychoticsside effectsPsychotic DisordersTolerabilitychemistryQuetiapineAntipsychotics; Psychiatry; Psychosis; Safety; Side effects; Tolerability; Medicine (all); Safety Research; Pharmacology Toxicology and Pharmaceutics (all); Chemical Health and Safety; Pharmacology (medical)Therapeutics. PharmacologyAntipsicóticosbusinessSafety Research030217 neurology & neurosurgeryAntipsychotic Agentsmedicine.drugTherapeutics and Clinical Risk Management
researchProduct

Associations of neuropsychiatric symptoms and antidepressant prescription with survival in Alzheimer's disease

2017

Objective Depression is associated with increased mortality in community samples. The use of antidepressant medication may also increase mortality, however, it is still unclear whether taking antidepressants before or after a diagnosis of dementia influences survival. Design Retrospective. Setting A cohort with a diagnosis of Alzheimer disease (AD) from a large mental health and dementia care database in South London, linked to hospitalization and mortality data. Participants Mild dementia (Mini-Mental State Examination ≥18/30) at the point of diagnosis. Measurements We ascertained antidepressant prescription, either in the 6 months before or after dementia diagnosis, and used the HoNOS65+,…

Malemedicine.medical_specialtyPediatricsDatabases FactualDementia; antidepressants; depression; mortalityKaplan-Meier EstimateNeuropsychological TestsRisk AssessmentSeverity of Illness Index03 medical and health sciencesSex Factors0302 clinical medicineAlzheimer DiseasemedicineHumansDementia030212 general & internal medicineMedical prescriptionRisk factorPsychiatryGeneral NursingDepression (differential diagnoses)AgedProportional Hazards ModelsRetrospective StudiesAged 80 and overDepressive Disorderbusiness.industryHealth PolicyHazard ratioAge FactorsGeneral MedicineMiddle AgedPrognosismedicine.diseaseSurvival AnalysismortalityAntidepressive AgentsConfidence intervalantidepressantsdepressionCohortFemaleDementiaGeriatrics and GerontologyAlzheimer's diseasebusinessdementia mortality030217 neurology & neurosurgery
researchProduct

Depression and physical health multimorbidity: primary data and country-wide meta-analysis of population data from 190 593 people across 43 low- and …

2017

BackgroundDespite the known heightened risk and burden of various somatic diseases in people with depression, very little is known about physical health multimorbidity (i.e. two or more physical health co-morbidities) in individuals with depression. This study explored physical health multimorbidity in people with clinical depression, subsyndromal depression and brief depressive episode across 43 low- and middle-income countries (LMICs).MethodCross-sectional, community-based data on 190 593 individuals from 43 LMICs recruited via the World Health Survey were analysed. Multivariable logistic regression analysis was done to assess the association between depression and physical multimorbidity…

AdultMalemedicine.medical_specialtymultimorbidityKey words DepressionAdolescentHealth StatusLogistic regressionGlobal HealthOdds03 medical and health sciencesYoung Adult0302 clinical medicinemedicineGlobal healthHumanslow- and middle-income countries030212 general & internal medicineSomatization disorderPsychiatryDeveloping CountriesApplied PsychologyDepression (differential diagnoses)AgedDepression low- and middle-income countries multimorbidity physical health psychiatryDepressive Disorderbusiness.industryDepressionMultimorbidityOdds ratioMiddle Agedmedicine.diseaseComorbiditypsychiatryPsychiatry and Mental healthCross-Sectional StudiesMeta-analysisFemalebusinessKey words Depression; low- and middle-income countries; multimorbidity; physical health; psychiatry; Applied Psychology; Psychiatry and Mental Healthphysical health030217 neurology & neurosurgeryDemographyPsychological medicine
researchProduct

The epidemiology of back pain and its relationship with depression, psychosis, anxiety, sleep disturbances, and stress sensitivity: Data from 43 low-…

2016

Background Back pain (BP) is a leading cause of global disability. However, population-based studies investigating its impact on mental health outcomes are lacking, particularly among low- and middle-income countries (LMICs). Thus, the primary aims of this study were to: (1) determine the epidemiology of BP in 43 LMICs; (2) explore the relationship between BP and mental health (depression spectrum, psychosis spectrum, anxiety, sleep disturbances and stress). Methods Data on 190,593 community-dwelling adults aged ≥18 years from the World Health Survey (WHS) 2002–2004 were analyzed. The presence of past-12 month psychotic symptoms and depression was established using questions from the Compos…

MaleStress sensitivitySleep problemsComorbidityAnxietyGlobal Health0302 clinical medicine030212 general & internal medicinepsychosislow- and middle-income countriesDepression (differential diagnoses)Aged 80 and overSleep disordereducation.field_of_studyLow- and middle-income countriesDepressionchronic back painMiddle AgedanxietyBack pain Chronic back pain Mental health Mental illness Depression Psychosis Anxiety Sleep problems Stress sensitivity Low- and middle-income countriesmental illnessAnxiety DisordersPsychiatry and Mental healthMental illnessdepressionAnxietyMental healthFemalemedicine.symptomPsychologymental healthClinical psychologyAnxiety; Back pain; Chronic back pain; Depression; Low- and middle-income countries; Mental health; Mental illness; Psychosis; Sleep problems; Stress sensitivityAdultSleep Wake Disordersmedicine.medical_specialtyAnxiety Back pain Chronic back pain Depression Low- and middle-income countries Mental health Mental illness Psychosis Sleep problems Stress sensitivityAdolescentPopulationChronic back painBF03 medical and health sciencesYoung AdultmedicineHumansPsychiatryeducationDeveloping CountriesAgedsleep problemsDepressive Disorderstress sensitivityBack painOdds ratiomedicine.diseaseMental illnessPsychosisMental healthComorbidityPsychotic DisordersBack Pain030217 neurology & neurosurgeryStress Psychological
researchProduct

Perceived Stress and Mild Cognitive Impairment among 32,715 Community-Dwelling Older Adults across Six Low- and Middle-Income Countries

2018

<b><i>Background:</i></b> Perceived stress may be a modifiable risk factor for mild cognitive impairment (MCI) and ultimately dementia, but studies on this topic from low- and middle-income countries (LMICs) are lacking. <b><i>Objective:</i></b> We assessed the association between perceived stress and MCI in six LMICs (China, Ghana, India, Mexico, Russia, and South Africa) using nationally representative data. <b><i>Methods:</i></b> Cross-sectional, community-based data on individuals aged ≥50 years from the World Health Organization’s Study on Global Ageing and Adult Health were analyzed. The definition of MCI was base…

MaleAgingGeriatrics & GerontologyInternational CooperationPerceived Stress ScaleLogistic regressionINCREASECognitionRisk FactorsPrevalencePerceived streProspective cohort studyDepression (differential diagnoses)RISK*CognitionDepressionDEMENTIAConfoundingPerceived stressMiddle AgedDEPRESSION*Risk factorALZHEIMERS-DISEASEFemaleIndependent LivingHEALTHLife Sciences & BiomedicineArticleOddsmedicineDementiaHumansCognitive DysfunctionGLUCOCORTICOIDSRisk factorDeveloping CountriesAgedDECLINEScience & Technologybusiness.industrymedicine.diseaseMODELREDUCTIONCross-Sectional StudiesSocioeconomic Factors*Perceived stressRisk factorGeriatrics and GerontologybusinessStress PsychologicalDemography
researchProduct

Perceived Stress and Its Relationship with Chronic Medical Conditions and Multimorbidity among 229,293 Community-Dwelling Adults in 44 Low- and Middl…

2017

In this study, we assessed the association of chronic medical conditions and multimorbidity with perceived stress among community-dwelling adults in 44 low- and middle-income countries. Data from the World Health Survey (2002-2004), including 229,293 adults, were analyzed. A perceived stress score (range, 0 (lowest stress)-100 (highest stress)) was computed on the basis of 2 questions from the Perceived Stress Scale. Eleven chronic conditions were assessed.Multivariable linear regression analyses were conducted to explore the associations. All chronic conditions were associated with significantly higher mean perceived stress scores, with the exception of edentulism. The associations were pa…

AdultMalemultimorbidityEpidemiologyCross-sectional studypovertyPerceived Stress ScaleComorbidityGlobal Healthchronic conditionYoung Adult03 medical and health sciences0302 clinical medicinechronic conditions low- and middle-income countries multimorbidity perceived stress povertymedicineHumans030212 general & internal medicineYoung adultDepression (differential diagnoses)AgedAsthmaAged 80 and overEdentulismbusiness.industryMental DisordersMiddle Agedmedicine.diseaseHealth SurveysComorbidityConfidence intervalCross-Sectional StudiesSocioeconomic Factorsperceived strelow- and middle-income countrieChronic DiseaseIncomeFemalebusinessStress Psychological030217 neurology & neurosurgeryDemography
researchProduct

Depression and pain: primary data and meta-analysis among 237 952 people across 47 low- and middle-income countries

2017

BackgroundDepression and pain are leading causes of global disability. However, there is a paucity of multinational population data assessing the association between depression and pain, particularly among low- and middle-income countries (LMICs) where both are common. Therefore, we investigated this association across 47 LMICs.MethodsCommunity-based data on 273 952 individuals from 47 LMICs were analysed. Multivariable logistic and linear regression analyses were performed to assess the association between the International Classification of Diseases, 10th Revision depression/depression subtypes (over the past 12 months) and pain in the previous 30 days based on self-reported data. Country…

AdultMalemedicine.medical_specialtyAdolescentComorbidityAnxietyLogistic regressionGlobal HealthSeverity of Illness IndexComorbidity; depression; depressive symptoms; pain; Applied Psychology; Psychiatry and Mental HealthAngina03 medical and health sciencesYoung Adult0302 clinical medicinedepressive symptomsInternal medicinePrevalenceMedicineHumanspainPsychiatrydepressive symptomDeveloping CountriesApplied PsychologyDepression (differential diagnoses)AgedAged 80 and overDepressive Disorderbusiness.industryPain scaleOdds ratioMiddle Agedmedicine.diseaseHealth SurveysConfidence interval030227 psychiatryPsychiatry and Mental healthMeta-analysisChronic DiseasedepressionAnxietyFemalemedicine.symptombusinessComorbidity depression depressive symptoms pain030217 neurology & neurosurgery
researchProduct

The association of depression and all-cause and cause-specific mortality: An umbrella review of systematic reviews and meta-analyses

2018

Background Depression is a prevalent and disabling mental disorder that frequently co-occurs with a wide range of chronic conditions. Evidence has suggested that depression could be associated with excess all-cause mortality across different settings and populations, although the causality of these associations remains unclear. Methods We conducted an umbrella review of systematic reviews and meta-analyses of observational studies. PubMed, PsycINFO, and Embase electronic databases were searched through January 20, 2018. Systematic reviews and meta-analyses that investigated associations of depression and all-cause and cause-specific mortality were selected for the review. The evidence was g…

EXCESS MORTALITYmental disorderSurvivalENVIRONMENTAL RISK-FACTORS*Meta-analysesPsychological interventionlcsh:MedicineCREDIBILITY CEILINGSPsycINFOUNIPOLAR DEPRESSIONACUTE CORONARY SYNDROME0302 clinical medicineMedicine*Cause-specific030212 general & internal medicineDepression (differential diagnoses)METABOLIC SYNDROMEPsychiatryDepressionConfoundingSEVERE MENTAL-ILLNESSBIPOLAR DISORDERGeneral Medicine11 Medical And Health SciencesCausalityCause-specificSystematic reviewHEART-FAILURE*Mortality*Umbrella reviewLife Sciences & Biomedicine*SurvivalResearch ArticleBF*All-cause03 medical and health sciencesUmbrella reviewMedicine General & InternalGeneral & Internal MedicineHumansMortalityCARDIOVASCULAR EVENTSDepressive DisorderScience & Technologybusiness.industrylcsh:RAll-causeSystematic reviews*Depression030227 psychiatryPROGNOSTIC ASSOCIATIONMYOCARDIAL-INFARCTIONMeta-analysesStructured interview*PsychiatryObservational study*Systematic reviewsbusinessDemography
researchProduct

The emergence of loss of efficacy during antidepressant drug treatment for major depressive disorder: An integrative review of evidence, mechanisms, …

2018

The re-emergence (i.e. ‘breakthrough’) of depressive symptoms despite maintenance treatment of depression with antidepressant drugs is a complex clinical phenomenon referred to as tolerance. Herein we critically appraise evidence from both pre-clinical and clinical studies, focusing on putative mechanisms as well as clinical correlates and implications of the emergence tolerance during antidepressant treatment for major depressive disorder (MDD). It is firstly unclear to what extent this phenotype reflects a pharmacological effect of an antidepressant, is driven by non-adherence, is a marker of latent bipolarity or another comorbidity, a marker of neuroprogression of the underlying disorder…

0301 basic medicineEmotional bluntingLoss of efficacyAntidepressantTreatment-resistanceSerotonergicloss of response03 medical and health sciences0302 clinical medicinetachyphylaxisMedicineRelapseswitch.Depression (differential diagnoses)treatment-resistancerelapsePharmacologyantidepressantwithdrawalbusiness.industryOperational definitionSwitchloss of efficacymedicine.diseaseComorbidity030104 developmental biologyWithdrawal030220 oncology & carcinogenesisMajor depressive disorderAntidepressantLoss of responsebusinessTachyphylaxiTolerancePsychosocialClinical psychologyPharmacological Research
researchProduct

Physical activity correlates among people with psychosis: Data from 47 low- and middle-income countries

2018

Background: People with schizophrenia engage in low levels of physical activity (PA). However, few large-scale studies have investigated the factors that may influence PA participation in individuals with psychosis and data from low- and middle-income countries (LMICs) is especially scarce. Thus, we investigated PA correlates in a large sample of people with a psychosis diagnosis across 47 LMICs. Methods: Cross-sectional data from the World Health Survey, restricting to those with a self-reported lifetime diagnosis of schizophrenia/psychotic disorder, was analyzed. PA was assessed by the International Physical Activity Questionnaire (IPAQ) and participants were dichotomized into those that …

MaleHealth BehaviorPsychological intervention*PsychosisGlobal Health0302 clinical medicine*Developing countries/dk/atira/pure/subjectarea/asjc/2800/2803Developing countrie*ExerciseMobilityPsychiatry/dk/atira/pure/subjectarea/asjc/2700/2738*Physical activityPsychiatry and Mental healthSchizophreniaPsychiatry and Mental HealthMarital statusAnxietyFemaleBiological psychiatrymedicine.symptomPsychologyPsychosismedicine.medical_specialtyDeveloping countries; Exercise; Mobility; Physical activity; Psychiatry; Psychosis; Schizophrenia; Psychiatry and Mental Health; Biological PsychiatryPsychosiDeveloping countries03 medical and health sciencesmedicineHumansPsychiatryExerciseBiological PsychiatryPhysical activity*SchizophreniaOdds ratiomedicine.diseasePsychosisHealth Surveys030227 psychiatryCross-Sectional StudiesPsychotic DisordersSocioeconomic FactorsSchizophrenia*Psychiatry*Mobility030217 neurology & neurosurgeryDemographyDiagnosis of schizophrenia
researchProduct

Relationship between depression and frailty in older adults: A systematic review and meta-analysis

2017

Aim Depression and frailty are prevalent and burdensome in older age. However, the relationships between these entities are unclear and no quantitative meta- analysis exists. We conducted a systematic review and meta-analysis to investigate the associations between depression and frailty. Methods Two authors searched major electronic databases from inception until November-2016 for cross-sectional/longitudinal studies investigating depression and frailty. The strength of the reciprocal associations between frailty and depression was assessed through odds ratios (ORs) adjusted for potential confounders. Results From 2306 non duplicated hits, 24 studies were included. The overall prevalence o…

GerontologyAgingCross-sectional studyDepression; Frail; Geriatrics; Meta-analysis; Older adults; Psychiatry; Biotechnology; Biochemistry; Aging; Molecular Biology; NeurologyFrail ElderlyBiochemistryPsiquiatra03 medical and health sciencesDepression Frail Geriatrics Older adults Meta-analysis Psychiatry0302 clinical medicineFrailRisk FactorsPrevalenceMedicineHumans030212 general & internal medicineRisk factorMolecular BiologyDepression (differential diagnoses)AgedAged 80 and overPsychiatryFrailtybusiness.industryDepressionIncidenceConfoundingPublication biasOdds ratioLate life depressionMeta-analysisCross-Sectional StudiesNeurologyGeriatricsMeta-analysisOlder adultsbusiness030217 neurology & neurosurgeryBiotechnology
researchProduct

Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies

2017

Objective: To conduct a systematic review and meta-analysis of studies that measured cytokine and chemokine levels in individuals with major depressive disorder (MDD) compared to healthy controls (HCs). Method: The PubMed/MEDLINE, EMBASE, and PsycINFO databases were searched up until May 30, 2016. Effect sizes were estimated with random-effects models. Result: Eighty-two studies comprising 3212 participants with MDD and 2798 HCs met inclusion criteria. Peripheral levels of interleukin-6 (IL-6), tumor necrosis factor (TNF)-alpha, IL-10, the soluble IL-2 receptor, C-C chemokine ligand 2, IL-13, IL-18, IL-12, the IL-1 receptor antagonist, and the soluble TNF receptor 2 were elevated in patient…

MaleChemokinePeripheral cytokinemedicine.drug_classmedicine.medical_treatmentInflammationchemokinesbehavioral disciplines and activities03 medical and health sciences0302 clinical medicinemental disordersHumansMedicineReceptorDepressive Disorder Majorbiologybusiness.industrychemokines; cytokines; depression; inflammation; meta-analysis; Psychiatry and Mental HealthReceptor antagonistmedicine.diseasecytokines030227 psychiatrymeta-analysisCytokineinflammationPsychiatry and Mental HealthMeta-analysisImmunologydepressionbiology.proteinMajor depressive disorderFemaleTumor necrosis factor alphamedicine.symptombusiness030217 neurology & neurosurgery
researchProduct

Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews

2017

Introduction. A burgeoning number of systematic reviews considering lurasidone in the treatment of bipolar depression have occurred since its Food and Drug Administration extended approval in 2013. While a paucity of available quantitative evidence still precludes preliminary meta-analysis on the matter, the present quality assessment of systematic review of systematic reviews, nonetheless, aims at highlighting current essential information on the topic. Methods. Both published and unpublished systematic reviews about lurasidone mono- or adjunctive therapy in the treatment of bipolar depression were searched by two independent authors inquiring PubMed/Cochrane/Embase/Scopus from inception u…

Genetics and Molecular Biology (all)Transtorno Bipolarmedicine.medical_specialtyBipolar DisorderImmunology and Microbiology (all)ConcordanceDrug profileAlternative medicineMEDLINElcsh:MedicineReview ArticleBiochemistryGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciencesLurasidone Hydrochloride0302 clinical medicineImmunology and Microbiology (all); Biochemistry Genetics and Molecular Biology (all)medicineBipolar DepressionHumansPsychiatryDrug ApprovalDepression (differential diagnoses)LurasidoneGeneral Immunology and Microbiologybusiness.industrylcsh:RGeneral Medicine030227 psychiatrySystematic reviewTolerabilityDepressãobusiness030217 neurology & neurosurgerymedicine.drugLurasidone
researchProduct

Perceived stress and smoking across 41 countries: A global perspective across Europe, Africa, Asia and the Americas

2017

Within recent years, there has been a seismic shift in smoking rates from high-income to low- and middle-income countries (LMICs). Evidence indicates that perceived stress may comprise a barrier for smoking cessation, but little is known about the association of perceived stress and smoking in LMICs. We conducted a cross-sectional, community-based study comprising 217,561 people [mean age 38.5 (SD = 16.1) years, 49.4% males]. A perceived stress score [range 2 (lowest-stress) 10 (highest-stress)] was computed from the Perceived Stress Scale. Multivariable logistic regression analyses were conducted. In the overall sample, a one-unit increase in perceived-stress resulted in a 5% increased odd…

GerontologyAdultMalemedicine.medical_specialtyMultivariate analysisAsiaCross-sectional studySciencemedicine.medical_treatmentDeveloping countryPerceived Stress ScaleLogistic regressionArticle03 medical and health sciences0302 clinical medicineMIDDLE-INCOME COUNTRIESmedicineHumansTOBACCO SMOKING030212 general & internal medicineProspective cohort studyDeveloping CountriesPovertyAgedHEALTH SURVEYSMultidisciplinarybusiness.industryPublic healthQRMiddle AgedEuropeCross-Sectional StudiesLogistic ModelsAfricaMultivariate AnalysisIncomeMedicineSmoking cessationFemalePerceptionSmoking CessationCIGARETTE-SMOKINGAmericasbusiness030217 neurology & neurosurgeryStress PsychologicalDemography
researchProduct

Pain perception in Parkinson's disease: A systematic review and meta-analysis of experimental studies

2017

While hyperalgesia (increased pain sensitivity) has been suggested to contribute to the increased prevalence of clinical pain in Parkinson's disease (PD), experimental research is equivocal and mechanisms are poorly understood. We conducted a meta-analysis of studies comparing PD patients to healthy controls (HCs) in their response to experimental pain stimuli. Articles were acquired through systematic searches of major databases from inception until 10/2016. Twenty-six studies met inclusion criteria, comprising 1292 participants (PD = 739, HCs = 553). Random effects meta-analysis of standardized mean differences (SMD) revealed lower pain threshold (indicating hyperalgesia) in PD patients d…

Agingmedicine.medical_specialtyParkinson's diseaseDopamineAnalgesicDopaminaStimulationDiseaseBiochemistry03 medical and health sciences0302 clinical medicinesystematic reviewDopamineInternal medicineThreshold of painmedicineHumanspain030212 general & internal medicineMolecular Biologybusiness.industryPain PerceptionParkinson DiseaseParkinson’s disease Dopamine Pain Meta-analysis Systematic reviewmedicine.diseasemeta-analysisNeurologyHyperalgesiaMeta-analysisHyperalgesiaPhysical therapyParkinson’s diseaseDoença de Parkinsonmedicine.symptomdopaminebusiness030217 neurology & neurosurgeryBiotechnologymedicine.drug
researchProduct

Depression comorbid with tuberculosis and its impact on health status: cross-sectional analysis of community-based data from 48 low- and middle-incom…

2017

Background Depression in tuberculosis increases the risk for adverse health outcomes. However, little is known about comorbid depression and tuberculosis in the general population. Thus, we assessed the association between depression and tuberculosis, and the decrements in health status associated with this comorbidity in 48 low- and middle-income countries. Methods Cross-sectional, community-based data from the World Health Survey on 242,952 individuals aged ≥ 18 years were analyzed. Based on the World Mental Health Survey version of the Composite International Diagnostic Interview, past 12-month depression was categorized into depressive episode, brief depressive episode, subsyndromal dep…

Male*Low- and middle-income countriesEpidemiologyHealth Statuslcsh:MedicineComorbidity*EpidemiologyGlobal Health0302 clinical medicineRisk FactorsEpidemiologyPrevalenceNot known030212 general & internal medicineDepressió psíquicaDepression (differential diagnoses)education.field_of_studyLow- and middle-income countriesDepressionGeneral MedicineMiddle Aged3. Good healthMental depressionIncomeFemaleResearch ArticleManagement of depressionAdultDepression; Epidemiology; Low- and middle-income countries; Tuberculosismedicine.medical_specialtyTuberculosisTuberculosiPopulationPain03 medical and health sciencesComorbiditatmedicineHumansTuberculosisEpidemiologiaPsychiatryeducationAgedbusiness.industryPublic healthlcsh:R*Depressionmedicine.diseaseHealth SurveysMental healthComorbiditySelf CareCross-Sectional StudiesSocial Classbusiness*Tuberculosis030217 neurology & neurosurgeryBMC Medicine
researchProduct

The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness.

2019

The poor physical health of people with mental illness is a multifaceted, transdiagnostic, and global problem. People with mental illness have an increased risk of physical disease, as well as reduced access to adequate health care. As a result, physical health disparities are observed across the entire spectrum of mental illnesses in low-income, middle-income, and high-income countries. The high rate of physical comorbidity, which often has poor clinical management, drastically reduces life expectancy for people with mental illness, and also increases the personal, social, and economic burden of mental illness across the lifespan. This Commission summarises advances in understanding on the…

medicine.medical_specialtyHealth StatusDiseaseComorbidity03 medical and health sciences0302 clinical medicineHealth caremedicineHumans030212 general & internal medicinePsychiatryBiological PsychiatryHealth policybusiness.industryPhysical health mental illnessMental DisordersMental illnessmedicine.diseaseComorbidityMental health030227 psychiatryPsychiatry and Mental healthHealth promotionPractice Guidelines as TopicLife expectancybusinessPsychologyThe lancet. Psychiatry
researchProduct

Associations between mental and oral health in Spain: a cross-sectional study of more than 23,000 people aged 15 years and over.

2020

Background:\ud \ud This study aimed to investigate associations between mental health and several parameters of oral health, controlling for a variety of important covariates, in a large representative sample of Spanish people.\ud \ud Methods:\ud \ud Data from the Spanish National Health Survey 2017 were analysed. Mental (i.e., depression, chronic anxiety, other psychiatric disorders) and oral health (i.e., dental caries, dental extraction, dental filling, gingival bleeding, tooth movement, dental material, missing tooth) were evaluated. Control variables included sex, age, marital status, education, smoking, alcohol consumption, and physical multimorbidity. Associations between psychiatric…

MaleMental health oral health marital status cross-sectional study SpainAdolescentCross-sectional studyPopulationmacromolecular substancesDental CariesRate ratio03 medical and health sciencessymbols.namesake0302 clinical medicineHumansMedicinecross-sectional studyMental health Spain cross-sectional study marital status oral health030212 general & internal medicinePoisson regressiona cross-sectional study of more than 23000 people aged 15 years and over- JOURNAL OF AFFECTIVE DISORDERS cilt.274 ss.67-72 2020 [Jacob L. Lopez-Sanchez G. F. Carvalho A. F. Shin J. I. Oh H. Yang L. Veronese N. SOYSAL P. Grabovac I. Koyanagi A. et al. -Paper Associations between mental and oral health in Spain]educationDepression (differential diagnoses)education.field_of_studybusiness.industry030206 dentistryMiddle AgedMental healthConfidence interval3. Good healthPsychiatry and Mental healthClinical Psychologystomatognathic diseasesCross-Sectional StudiesSpain[SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthsymbolsMarital statusoral healthFemaleMental healthbusinessDemographymarital status
researchProduct

Oxidative stress and frailty : a systematic review and synthesis of the best evidence

2017

Objective Oxidative stress (OS) is associated with accelerated aging. Previous studies have suggested a possible relationship between OS and frailty but this association remains unclear. We conducted a systematic review to investigate potential interactions between OS and frailty. Methods A systematic literature search of original reports providing data on ‘OS and antioxidant’ parameters and frailty was carried out across major electronic databases from inception until May 2016. Cross-sectional/case control and longitudinal studies reporting data on the association between frailty and anti-oxidants-OS biomarkers were considered for inclusion. Results were summarized with a synthesis based o…

0301 basic medicineOncologyGerontologyGenetics and Molecular Biology (all)AgingCross-sectional studyalpha-TocopherolAntioxidantesIsoprostanesmedicine.disease_causeBiochemistryAnti-oxidantAntioxidants0302 clinical medicineLongitudinal StudiesAged 80 and overFrailtyGlutathione DisulfideObstetrics and GynecologyGlutathione8-Hydroxy-2'-DeoxyguanosineSystematic searchAnti-oxidant; Frail; Frailty; Oxidative stress; Biochemistry Genetics and Molecular Biology (all); Obstetrics and Gynecologymedicine.medical_specialtyFrail ElderlyGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciencesFrailInternal medicinemedicineHumansFrail elderlySulfhydryl CompoundsAgedAldehydesbusiness.industryCase-control studyFrailty Frail Oxidative stress Anti-oxidantEstresse OxidativoDeoxyguanosineMean ageOxidized GlutathioneOxidative Stress030104 developmental biologyCross-Sectional Studies1-Alkyl-2-acetylglycerophosphocholine EsteraseBest evidencebusinessReactive Oxygen Species030217 neurology & neurosurgeryOxidative stressBiomarkers
researchProduct

Mapping risk factors for depression across the lifespan: An umbrella review of evidence from meta-analyses and Mendelian randomization studies

2018

The development of depression may involve a complex interplay of environmental and genetic risk factors. PubMed and PsycInfo databases were searched from inception through August 3, 2017, to identify meta-analyses and Mendelian randomization (MR) studies of environmental risk factors associated with depression. For each eligible meta-analysis, we estimated the summary effect size and its 95% confidence interval (CI) by random-effects modeling, the 95% prediction interval, heterogeneity with I 2 , and evidence of small-study effects and excess significance bias. Seventy meta-analytic reviews met the eligibility criteria and provided 134 meta-analyses for associations from 1283 primary studie…

MOOD DISORDERSPUBLISHED LITERATURELongevityPsycINFORisk Assessment17 Psychology And Cognitive Sciences03 medical and health sciencesUmbrella review0302 clinical medicineMendelian randomizationIMPAIRED GLUCOSE-METABOLISMmedicineHumansOLDER-ADULTSBiological PsychiatryDepression (differential diagnoses)PsychiatryScience & Technologybusiness.industryDepressionPreventiongenetic risk factorPrediction intervalMAJOR DEPRESSION11 Medical And Health SciencesMendelian Randomization Analysismedicine.diseaseADEQUATE PARENTAL CAREMental healthConfidence intervalADULT DEPRESSION030227 psychiatryDepression; Meta-analyses; Prevention; Psychiatry; Risk factors; Umbrella reviewSYSTEMATIC REVIEWSPsychiatry and Mental healthSystematic reviewMood disordersRisk factorsMeta-analysesINDIVIDUAL PARTICIPANT DATAbusinessLife Sciences & BiomedicineMENTAL-HEALTH030217 neurology & neurosurgeryDemography
researchProduct

Systematic review and exploratory meta-analysis of the efficacy, safety, and biological effects of psychostimulants and atomoxetine in patients with …

2019

ObjectiveOur aim was to summarize the efficacy and safety of atomoxetine, amphetamines, and methylphenidate in schizophrenia.MethodsWe undertook a systematic review, searching PubMed/Scopus/Clinicaltrials.gov for double-blind, randomized, placebo-controlled studies of psychostimulants or atomoxetine in schizophrenia published up to 1 January 2017. A meta-analysis of outcomes reported in two or more studies is presented.ResultsWe included 22 studies investigating therapeutic effects of stimulants (k=14) or measuring symptomatic worsening/relapse prediction after stimulant challenge (k=6). Six studies of these two groups plus one additional study investigated biological effects of psychostimu…

safetymedicine.medical_specialtyPsychosismedicine.medical_treatmentefficacyamphetamineSchizoaffective disorderAtomoxetine Hydrochloridemeta-analysi03 medical and health sciencesExecutive Function0302 clinical medicinesystematic reviewInternal medicinemedicineHumansAttentionAmphetamineProblem Solvingbusiness.industryMethylphenidateAtomoxetineAmphetaminesrelapse predictorstimulantmedicine.disease030227 psychiatryStimulantPsychiatry and Mental healthMemory Short-Termamphetamine atomoxetine efficacy meta-analysis methylphenidate relapse predictor safety schizophrenia stimulants systematicn reviewPsychotic DisordersSchizophreniaMeta-analysisMethylphenidateSchizophreniaNeurology (clinical)businessatomoxetine030217 neurology & neurosurgerymedicine.drugAntipsychotic Agents
researchProduct

A meta-review of “lifestyle psychiatry”: the role of exercise, smoking, diet and sleep in the prevention and treatment of mental disorders

2020

There is increasing academic and clinical interest in how "lifestyle factors" traditionally associated with physical health may also relate to mental health and psychological well-being. In response, international and national health bodies are producing guidelines to address health behaviors in the prevention and treatment of mental illness. However, the current evidence for the causal role of lifestyle factors in the onset and prognosis of mental disorders is unclear. We performed a systematic meta-review of the top-tier evidence examining how physical activity, sleep, dietary patterns and tobacco smoking impact on the risk and treatment outcomes across a range of mental disorders. Result…

medicine.medical_specialtyPsychological interventiondietary patternsphysical activityLifestyle factorslaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialanxiety disorderslawmedicineANXIETYBipolar disordertobacco smokingsleepLifestyle factors mental disorders psychological well-being physical activity sedentary behavior tobacco smoking dietary patterns sleep depression anxiety disorders bipolar disorder schizophreniaPsychiatryMETAANALYSISPsychiatrybipolar disorderRISKScience & Technologybusiness.industryPublic healthSEDENTARY BEHAVIORResearch ReportsASSOCIATIONADULTSMental illnessmedicine.diseaseMental healthHEALTH PROBLEMS030227 psychiatrymental disordersschizophreniaPsychiatry and Mental healthPHYSICAL-ACTIVITYSchizophreniaDEPRESSIVE SYMPTOMSdepressionMENDELIAN RANDOMIZATIONAnxietypsychological well-beingPshychiatric Mental Healthmedicine.symptombusinessLife Sciences & Biomedicine030217 neurology & neurosurgery
researchProduct

Depression, sleep problems, and perceived stress among informal caregivers in 58 low-, middle-, and high-income countries: A cross-sectional analysis…

2018

Caregiving has been associated with adverse health outcomes. However, there is a paucity of multi-country, population-based studies on mental health outcomes of caregivers especially from low- and middle-income countries (LMICs). Thus, we assessed the association of caregiving with depression, sleep problems, and perceived stress in 10 high-, 27 middle-, and 21 low-income countries. Cross-sectional community-based data of the World Health Survey including 258,793 adults aged ≥18 years were analyzed. Multivariable logistic and linear regression analyses were conducted to explore the association of past 12-month caregiving with past 12-month DSM-IV depression, and past 30-day perceived stress…

AdultMaleSleep Wake Disordersmedicine.medical_specialtyAdolescentCross-sectional studyPopulationPsychological interventionStresssleep problem03 medical and health sciencesYoung Adult0302 clinical medicineEnvironmental healthstreSurveys and QuestionnairesStress (linguistics)Journal ArticlemedicinePrevalenceHumans030212 general & internal medicinePsychiatryeducationDeveloping CountriesBiological PsychiatryDepression (differential diagnoses)Agededucation.field_of_studyCaregiving; Depression; Sleep; StressDepressionDeveloped CountriesConfoundingMiddle AgedMental healthSleep in non-human animalsPsychiatry and Mental healthCross-Sectional StudiesCaregiversCaregivingRegression AnalysisFemalePerceptionPsychologySleep030217 neurology & neurosurgeryStress PsychologicalJournal of psychiatric research
researchProduct

Use of statins and the risk of dementia and mild cognitive impairment: a systematic review and meta-analysis

2018

AbstractWe conducted a systematic review and meta-analysis to investigate whether the use of statins could be associated with the risk of all-caused dementia, Alzheimer’s disease (AD), vascular dementia (VaD), and mild cognitive impairment (MCI). Major electronic databases were searched until December 27th, 2017 for studies investigating use of statins and incident cognitive decline in adults. Random-effects meta-analyses calculating relative risks (RRs) were conducted to synthesize effect sizes of individual studies. Twenty-five studies met eligibility criteria. Use of statins was significantly associated with a reduced risk of all-caused dementia (k = 16 studies, adjusted RR (aRR) = 0.849…

medicine.medical_specialtylcsh:MedicineSubgroup analysisRisk AssessmentArticle03 medical and health sciences0302 clinical medicinemild cognitive impairmentInternal medicineMedicineDementiaHumansCognitive Dysfunction030212 general & internal medicineCognitive declineProspective cohort studyVascular dementialcsh:ScienceMultidisciplinarybusiness.industrylcsh:RStatinInibidores de Hidroximetilglutaril-CoA Redutasesmedicine.diseaseRelative riskMeta-analysislcsh:QDementiaHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessRisk assessment030217 neurology & neurosurgerydementiaDemência
researchProduct

Prevalence of Catatonia and Its Moderators in Clinical Samples: Results from a Meta-analysis and Meta-regression Analysis

2017

Catatonia is an independent syndrome that co-occurs with several mental and medical conditions. We performed a systematic literature review in PubMed/Scopus until February 2017 and meta-analyzed studies reporting catatonia prevalence. Across 74 studies (cross-sectional = 32, longitudinal = 26, retrospective = 16) providing data collected from 1935 to 2017 across all continents, mean catatonia prevalence was 9.0% (k = 80, n = 110 764; 95% CI = 6.9-11.7, I2 = 98%, publication bias P < .01), decreasing to 7.8% (k = 19, n = 7612, 95% CI = 7-8.7, I2 = 38.9%) in a subgroup with low heterogeneity. Catatonia prevalence was 23.9% (k = 8, n = 1168, 95% CI = 10-46.9, I2 = 96%) in patients undergoin…

medicine.medical_specialtyCatatoniaTranstornos Mentaisprevalencemeta-analysiDSM-503 medical and health sciencesDSM5; catatonia; meta-analysis; prevalence; severe mental illness0302 clinical medicineDSM5catatonia meta-analysis DSM5 severe mental illness prevalenceRating scaleInternal medicinesevere mental illnessmedicineHumansMeta-regressionPsychiatryMental DisordersCatatoniaPublication biasmedicine.disease030227 psychiatrymeta-analysisPsychiatry and Mental healthSample size determinationMeta-analysisMajor depressive disordercatatoniaPsychology030217 neurology & neurosurgeryRegular Articles
researchProduct

Low-Dose Aspirin Use and Cognitive Function in Older Age: A Systematic Review and Meta-analysis

2017

Objectives:\ud \ud To investigate whether low-dose aspirin (<300 mg/d) can influence the onset of cognitive impairment or dementia in observational studies and improve cognitive test scores in randomized controlled trials (RCTs) in participants without dementia.\ud \ud Design:\ud \ud Systematic review and meta-analysis.\ud \ud Setting:\ud \ud Observational and interventional studies.\ud \ud Participants:\ud \ud Individuals with no dementia or cognitive impairment initially.\ud \ud Measurements:\ud \ud Odds ratios (ORs) and 95% confidence intervals (CIs), adjusted for the maximum number of covariates from each study, were used to summarize data on the incidence of dementia and cognitive impa…

Gerontologymedicine.medical_specialtyaspirinArticlelaw.invention03 medical and health sciencesCognition0302 clinical medicineRandomized controlled triallawaspirin; cognitive impairment; dementia; meta-analysis; Geriatrics and GerontologyInternal medicinemedicineHumansDementia030212 general & internal medicineCognitive declineRandomized Controlled Trials as Topiccognitive impairmentbusiness.industryAnti-Inflammatory Agents Non-SteroidalCognitionOdds ratiomedicine.diseaseCognitive testmeta-analysisMeta-analysisDementiaObservational studyGeriatrics and GerontologyCognition Disordersbusiness030217 neurology & neurosurgery
researchProduct

Acetyl-L-Carnitine Supplementation and the Treatment of Depressive Symptoms: A Systematic Review and Meta-Analysis.

2017

Objective: Deficiency of acetyl-l-carnitine (ALC) seems to play a role in the risk of developing depression, indicating a dysregulation of fatty acid transport across the inner membrane of mitochondria. However, data about ALC supplementation in humans are limited. We thus conducted a systematic review and meta-analysis investigating the effect of ALC on depressive symptoms across randomized controlled trials (RCTs). Methods: A literature search in major databases, without language restriction, was undertaken from inception until 30 December 2016. Eligible studies were RCTs of ALC alone or in combination with antidepressant medications, with a control group taking placebo/no intervention or…

medicine.medical_specialtyPlacebonot knownlaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicineMedicineHumansAdverse effectApplied PsychologyDepression (differential diagnoses)Randomized Controlled Trials as Topicbusiness.industryDepressionIncidence (epidemiology)Confidence intervalAntidepressive Agents030227 psychiatryPsychiatry and Mental healthMeta-analysisDietary SupplementsVitamin B ComplexAntidepressantbusinessAcetylcarnitine030217 neurology & neurosurgeryPsychosomatic medicine
researchProduct

Physical multimorbidity and psychosis: comprehensive cross sectional analysis including 242,952 people across 48 low- and middle-income countries.

2016

BACKGROUND: In people with psychosis, physical comorbidities, including cardiovascular and metabolic diseases, are highly prevalent and leading contributors to the premature mortality encountered. However, little is known about physical health multimorbidity in this population or in people with subclinical psychosis and in low- and middle-income countries (LMICs). This study explores physical health multimorbidity patterns among people with psychosis or subclinical psychosis. METHODS: Overall, data from 242,952 individuals from 48 LMICs, recruited via the World Health Survey, were included in this cross-sectional study. Participants were subdivided into those (1) with a lifetime diagnosis o…

MaleInternationalityCross-sectional studyComorbidityMetabolism Multimorbidity Physical health Psychosis Psychotic experiencesGlobal HealthLogistic regressionnot known0302 clinical medicinePrevalencepsychosisSubclinical infectionPsychosisPhysical healthMultimorbidityPsychotic experiencesMetabolismmetabolismmultimorbidityphysical healthpsychosispsychotic experiencesMedicine(all)Principal Component Analysiseducation.field_of_studyGeneral MedicineMiddle AgedCardiovascular DiseasesFemalemedicine.symptomAdultPsychosismedicine.medical_specialtyAdolescentmultimorbidityVisual impairmentPopulationPhysical healthYoung Adult03 medical and health sciencesMetabolic DiseasesmedicineHumansPsychotic experiencesPsychiatryeducationPovertyAgedbusiness.industryPublic healthMultimorbidityPsychosismedicine.diseaseHealth SurveysComorbidity030227 psychiatryCross-Sectional StudiesMetabolismPsychotic DisordersChronic Diseasebusiness030217 neurology & neurosurgery
researchProduct

The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta‐review of meta‐analyses of randomized controlled trials

2019

The role of nutrition in mental health is becoming increasingly acknowledged. Along with dietary intake, nutrition can also be obtained from "nutrient supplements", such as polyunsaturated fatty acids (PUFAs), vitamins, minerals, antioxidants, amino acids and pre/probiotic supplements. Recently, a large number of meta-analyses have emerged examining nutrient supplements in the treatment of mental disorders. To produce a meta-review of this top-tier evidence, we identified, synthesized and appraised all meta-analyses of randomized controlled trials (RCTs) reporting on the efficacy and safety of nutrient supplements in common and severe mental disorders. Our systematic search identified 33 me…

eicosapentaenoic acidNutrient supplements polyunsaturated fatty acids omega-3 eicosapentaenoic acid methylfolate vitamin D N-acetylcysteine depression schizophrenia attention-deficit/hyperactivity disorder adjunctive treatmentvitamin Dlaw.invention0302 clinical medicineRandomized controlled triallawL-METHYLFOLATEVITAMIN-D SUPPLEMENTATIONOXIDATIVE STRESSPsychiatryMAJOR DEPRESSIVE DISORDERPOLYUNSATURATED FATTY-ACIDSattention-deficitGUT MICROBIOTAPsychiatry and Mental healthNutrient supplementsCARDIOVASCULAR-DISEASESchizophreniadepressionhyperactivity disorderMajor depressive disorderomega-3Pshychiatric Mental HealthLife Sciences & Biomedicinepolyunsaturated fatty acidsmedicine.medical_specialtyDEFICIT HYPERACTIVITY DISORDERattention-deficit/hyperactivity disorder03 medical and health sciencesmedicineAttention deficit hyperactivity disorderPsychiatryAdverse effectIntensive care medicineScience & Technologybusiness.industrymethylfolateadjunctive treatmentResearch Reportsmedicine.diseaseNUTRITIONAL MEDICINEMental healthN-acetylcysteine030227 psychiatryschizophreniaMood disordersAdjunctive treatmentbusiness030217 neurology & neurosurgeryWorld Psychiatry
researchProduct